OncologyAromatase inhibitorIn stock
Letrozole
Also known as Femara
A non-steroidal aromatase inhibitor used as adjuvant treatment for hormone receptor-positive early breast cancer. Manufactured under GMP with full monograph compliance.
Full specification
Identity, quality, and supply.
- INN
- Letrozole
- CAS number
- 112809-51-5
- Molecular formula
- C17H11N5
- Molecular weight
- 285.3 g/mol
- Therapeutic area
- Oncology
- Therapeutic class
- Aromatase inhibitor
- Supplied as
- API
- Available scale
- Commercial
- Stock status
- In stock
- Storage
- As per COA
- Packaging
- HDPE drums, 10 kg net weight
- Brand names
- Femara
Highlights
What buyers care about.
- USP monograph compliance
- Full stability data package
Related molecules
Full catalogue